Skip to Main Content
Biological & Biomedical Sciences
Yale Home

INFORMATION FOR

    Sherry Agabiti, PhD

    Associate Research Scientist in Genetics
    DownloadHi-Res Photo

    About

    Titles

    Associate Research Scientist in Genetics

    Biography

    Sherry is an associate research scientist studying the impact of p53 mutants on tumor evolution. She received her undergraduate degree from the University of Connecticut in Physiology & Neurobiology and English and then completed her Ph.D. at the University of Connecticut in Pharmaceutical Sciences. Her long-term research interests include understanding tumor evolve to avoid apoptosis and identifying thera vulnerabilities in pancreatic and lung cancers. Outside the lab, she enjoys gardening, following Formula 1, and curling up with a cup of tea and a whodunnit.

    Last Updated on February 26, 2026.

    Appointments

    • Genetics

      Associate Research Scientist
      Primary
      Genetics

    Other Departments & Organizations

    Education & Training

    PhD
    University of Connecticut, Pharmaceutical Sciences
    BS
    University of Connecticut, Physiology/ Neurobiology, English

    Research

    Research at a Glance

    Yale Co-Authors

    Frequent collaborators of Sherry Agabiti's published research.

    Publications

    2026

    • Diet-induced phospholipid remodeling dictates ferroptosis sensitivity and tumorigenesis in the pancreas.
      Ruiz CF, Ge X, McDonnell R, Agabiti SS, McQuaid DC, Tang A, Kharwa M, Goodell J, Saavedra-Pena RDM, Wing A, Li G, Medici NP, Robert ME, Varshney RR, Rudolph MC, Gorelick FS, Wysolmerski J, Canals D, Haley JD, Rodeheffer MS, Muzumdar MD. Diet-induced phospholipid remodeling dictates ferroptosis sensitivity and tumorigenesis in the pancreas. Cancer Discov 2026 PMID: 42053430, DOI: 10.1158/2159-8290.CD-25-0734.
      Peer-Reviewed Original Research
      This study investigates how dietary fat composition influences pancreatic cancer, showing that monounsaturated fats promote tumor growth while polyunsaturated fats reduce risk by enhancing ferroptosis sensitivity.
      Full Summary
    • Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development
      Garcia CC, Venkat A, McQuaid DC, Agabiti SS, Tong A, Mathew B, Cardone RL, Starble R, Ruiz CF, Zheng C, Sogunro A, Jacox JB, Loh KH, Kibbey RG, Krishnaswamy S, Muzumdar MD. Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development. Nature Communications 2026 DOI: 10.1038/s41467-026-69821-2.
      Peer-Reviewed Original Research
      This study investigates how beta cell-derived cholecystokinin drives obesity-associated pancreatic cancer development, showing that targeting endocrine signaling could prevent tumor progression in obesity-related contexts.
      Full Summary

    Academic Achievements & Community Involvement

    Patents

    Get In Touch

    Contacts

    Email